|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 734.4 USD | +1.31% |
|
+1.21% | +26.11% |
| Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
| Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
On October 5, 2021, IpiNovyx Bio, Inc. closed the transaction. The transaction was led by new investor Viva BioInnovator. The transaction included participation from new investors Alexandria Venture Investments, LLC, Opaleye Management Inc., Eli Lilly and Company, and Orange Grove Bio, LLC.
The company has received $7,000,000 in funding from 12 investors pursuant to Regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.11% | 653B | |
| +27.00% | 556B | |
| -6.61% | 354B | |
| +20.92% | 331B | |
| +2.44% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.00% | 144B | |
| -11.31% | 143B |
ELI LILLY AND COMPANY 
